As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...

India's pharmaceutical landscape is on the verge of transformation! The country’s drug regulatory body is gearing up for an overhaul with t...

The message was conveyed through a public notice issued by The Central Drugs Standard Control Organisation (CDSCO) on May 4. It said applic...

India is taking a groundbreaking step forward in the realm of rare disease care with a distinctive approach that champions local ingenuity ...

Sun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...

Bluehill Capital, SOSV, and other global investors participated in the round. The Hyderabad- and US-based biotech startup will use the fund...

As per Bharat Biotech, the facility will tackle scientific challenges such as targeted gene expression, immune system modulation, and long-...

Bharat Biotech has invested $75 million in its first cell and gene therapy facility in Telangana, India, aiming to launch new therapies in ...

Researchers, including those from the Indian Institute of Technology-Bombay and Tata Memorial Hospital, Mumbai, said in low and middle-inco...

India is progressing in cell and gene therapy. Research includes treatments for leukemia, hemophilia-A, sickle-cell anemia, and more.

German biomedical discovery provider Miltenyi Biotec is launching operations in India, opening its first office and setting up a Centre of ...

The high cost of Zolgensma, a one-time gene therapy used to treat spinal muscular atrophy (SMA) in children under two, is to limited patien...

Limitless potential for future global advancements in gene therapies is originating from India, said Dr David Gamm.

The rare disease affects one in every 8,000 children. The bigger problem, according to parents and doctors, is the lack of awareness about ...

As Narayana Nethralaya is fronting it, the focus is on ocular (eye) diseases, though Ghosh’s own area of work is in muscular dystrophy.

Also called colon, rectal or bowel cancer, CRC is the third most common cancer in men and the second in women worldwide.